Abstract
Δ1-pyrroline-5-carboxylate synthase (P5CS) catalyses the reduction of glutamate to Δ1-pyrroline-5-carboxylate, a critical step in the biosynthesis of proline, ornithine and arginine. Recently, we reported a newly recognised inborn error due to deficiency of P5CS in two sibs, one presenting at birth with hypotonia, dysmorphic signs, pes planus and clonic seizures. Both developed progressive neurodegeneration and peripheral neuropathy, joint laxity, skin hyperelasticity and bilateral subcapsular cataracts. Their metabolic phenotype includes mild hyperammonaemia, hypo-ornithinaemia, hypocitrullinaemia, hypo-argininaemia and hypoprolinaemia. Incorporation of 3H-proline into protein was deficient in fibroblasts incubated with 3H-glutamate. Both patients are homozygous for the missense mutation R84Q in P5CS. Here, we describe the clinical phenotype of the sibs in detail and show that a relative deficiency of urea cycle intermediates (ornithine, citrulline and arginine) during fasting periods results in a paradoxical hyperammonaemia. Furthermore, we show the results of ornithine loading tests and indirect enzyme studies corroborating the biological significance of the defect in P5CS in vivo. Conclusion:The metabolic phenotype of Δ1-pyrroline-5-carboxylate synthase deficiency is easily missed. The combination of low levels of ornithine, citrulline, arginine and proline plus a tendency to hyperammonaemia or one of the above together with a clinical phenotype of neurodegeneration with peripheral neuropathy and/or cataracts and connective tissue manifestations should suggest this disorder. Early recognition would allow a therapeutic trial with citrulline and proline.
Similar content being viewed by others
Abbreviations
- P5C :
-
Δ1-pyrroline-5-carboxylate
- P5CS :
-
Δ1-pyrroline-5-carboxylate synthase
- OAT :
-
ornithine δ-aminotransferase
References
Baumgartner MR, Hu C-A, Almashanu S, Steel G, Obie C, Aral B, Rabier D, Kamoun P, Saudubray J-M, Valle D (2000) Hyperammonemia with reduced ornithine, citrulline, arginine and proline: A new inborn error caused by a mutation in the gene encoding Δ1-pyrroline-5-carboxylate synthase. Hum Molec Genet 9: 2853–2858
Brusilow SW, Horwich AL (2001) Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1909–1963
Crenn P, Vahedi K, Lavergne-Slove A, Matuchansky C, Messing B (2003) Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 124: 1210–1219
Dillon EL, Knabe DA, Wu G (1999) Lactate inhibits citrulline and arginine synthesis from proline in pig enterocytes. Am J Physiol 276: G1079–G1086
Hu C-A, Lin W-W, Obie C, Valle D (1999) Molecular enzymology of mammalian Δ1-pyrroline-5-carboxylate synthase. J Biol Chem 274: 6754–6762
Kamoun P, Aral B, Saudubray J-M (1998) A new inherited metabolic disease: Δ1 pyrroline 5-carboxylate synthetase deficiency. Bull Acad Natl Med 182: 131–139
Pappas P, Saudubray J-M, Tzakis A, Rabier D, Carreno M, Gomez-Marin O, Hujing F, Gelman B, Levi D, Nery J, Kato T, Mittal N, Nishida S, JF T, Ruiz P (2001) Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation 72: 1212–1216
Phang JM, Hu C-A, Valle D (2001) Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1821–1838
Rabier D, Diry C, Rotig A, Rustin P, Heron B, Bardet J, Parvy P, Ponsot G, Marsac C, Saudubray J-M, Munnich A, Kamoun P (1998) Persistant hypocitrullinemia as a marker for mtDNA NARP T8993G mutation? J Inherit Metab Dis 21: 216–219
Shafqat S, Velaz-Faircloth M, Henzi VA, Whitney KD, Yang-Feng TL, Seldin MF, Fremeau RTJ (1995) Human brain-specific l -proline transporter: molecular cloning, functional expression and chromosomal localization of the gene in human and mouse genomes. Molec Pharmacol 48: 219–229
Slocum R, Cummings J (1991) Amino acid analysis of physiological samples. In: Hommes F (ed) Techniques in diagnostic human biochemical genetics, a laboratory manual. Wiley-Liss, New York, pp 87–126
Smith RJ, Phang JM (1978) Proline metabolism in cartilage: the importance of proline biosynthesis. Metabolism 27: 685
Valle D, Simell O (2001) The hyperornithinemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1857–1895
Wakabayashi Y, Yamada E, Hasegawa T, Yamada R (1991) Enzymological evidence for the indispensability of small intestine in the synthesis of arginine from glutamate. I. Pyrroline-5-carboxylate synthase. Arch Biochem Biophys 291: 1–8
Acknowledgements
We thank B. Steinmann for careful reading and fruitful discussion of the manuscript. M. R. Baumgartner was supported by a grant from the Swiss National Foundation and the M. and W. Lichtenstein Stiftung. D. Valle is an Investigator in the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baumgartner, M.R., Rabier, D., Nassogne, MC. et al. Δ1-pyrroline-5-carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline. Eur J Pediatr 164, 31–36 (2005). https://doi.org/10.1007/s00431-004-1545-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-004-1545-3